David Tendler

Member, Board of Directors at New York Blood Center, Inc.

David Tendler

David Tendler

Member, Board of Directors at New York Blood Center, Inc.

Biography

David Tendler is Chairman at New York Blood Center, Inc.

Overview
RelSci Relationships

102

Number of Boards

4

Birthday

1938

Age

80

Relationships
RelSci Relationships are individuals David Tendler likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Director & Vice President-Operations at New York Blood Center, Inc.

Relationship likelihood: Strong

Chief Scientific Officer, National Cord Blood Program at New York Blood Center, Inc.

Relationship likelihood: Strong

Managing Director at Alvarez & Marsal Holdings, LLC

Relationship likelihood: Strong

Former President & Director at Pall Corporation

Relationship likelihood: Strong

Member, Board of Directors at New York Blood Center, Inc.

Relationship likelihood: Strong

Former Managing Partner at PrivateBancorp, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at New York Private Bank & Trust

Relationship likelihood: Strong

Senior Vice President-Chief Medical Officer at New York Blood Center, Inc.

Relationship likelihood: Strong

Former Chairman of the Board & Chief Executive Officer at Savient Pharmaceuticals, Inc.

Relationship likelihood: Strong

Senior Vice President & General Counsel at New York Blood Center, Inc.

Relationship likelihood: Strong

Paths to David Tendler
Potential Connections via
Relationship Science
You
David Tendler
Member, Board of Directors at New York Blood Center, Inc.
Boards & Committees
Director
Prior - 2005

Vitex is a Delaware Corporation incorporated in 1995. Vitex's scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development

Director
1994 - 2007

Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ.

Member, Board of Directors
Current

As one of the most preeminent and comprehensive blood centers in the world, NYBC operates under a four part mission. For more information, see sch. O and part iii, 4a-c.

Vice Chair, Board of Trustees
2014 - Prior

Part of New York Blood Center, Inc., Community Blood Center of Greater Kansas City is an American company located in Kansas City, MO. The firm operates blood distribution and research organizations. New York Blood Center, Inc. acquired Community Blood Center of Greater Kansas City on 04 Aug 14.An excerpt from the company's website reads as follows: Community Blood Center serves hospitals in the Greater Kansas City metropolitan area, as well as eastern Kansas and western Missouri. CBC provides nearly 200,000 blood products per year to nearly 60 area hospitals - and relies volunteer donors each day to meet the need for life-saving gifts of blood. CBC operates 365/24/7 to deliver safe, high-quality products to meet transfusion needs for routine care and emergencies.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$50K - $100K
2010

As one of the most preeminent and comprehensive blood centers in the world, NYBC operates under a four part mission. For more information, see sch. O and part iii, 4a-c.

$50K - $100K
2007

As one of the most preeminent and comprehensive blood centers in the world, NYBC operates under a four part mission. For more information, see sch. O and part iii, 4a-c.

$50K - $100K
2004

As one of the most preeminent and comprehensive blood centers in the world, NYBC operates under a four part mission. For more information, see sch. O and part iii, 4a-c.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Tendler. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Tendler's profile does not indicate a business or promotional relationship of any kind between RelSci and David Tendler.